CCND2 and prostate carcinoma: MiR-615 overexpression has been shown to suppress CCND2 mRNA and protein levels, inhibiting tumor progression, and restoration of Cyclin D2 expression partially reversed miR-615's inhibitory effects on prostate cancer cell proliferation, migration, and invasion [29].